CareSyntax
Surgical intelligence from OR data
NYC, MA, US
CareSyntax is a healthcare technology company founded in 2013 that focuses on improving surgical outcomes. It leverages IoT technology, AI, and data analytics to enhance surgical precision, patient safety, and operational efficiency within operating rooms globally.
How We Help
Problem Statement
The problem CareSyntax solves is the lack of precision, safety, and operational efficiency in surgical procedures, leading to suboptimal outcomes and resource management in operating rooms.
Core Technology
IoT technology, AI, and data analytics
Key Differentiators
Vendor-neutral surgical intelligence platform; collects and analyzes vast amounts of data (video, audio, images, device data, clinical and operational metrics) from inside the operating room, integrated with EHRs; utilized in over 4,200 operating rooms worldwide, supporting more than 3 million procedures annually.
Clinical Focus
Improving surgical outcomes across various procedures, enhancing surgical precision and patient safety.
Target Customers
Hospitals, health systems, medical device companies, insurers, other healthcare ecosystem players.
Product Stage
Mature
Company Info
- Business Model
- CareSyntax provides a vendor-neutral surgical intelligence platform that collects and analyzes data from operating rooms to optimize surgical workflows, offer real-time support, and provide post-procedure insights. It also offers data analytics and insights to medical device companies, insurers, and other healthcare ecosystem players.
- Founded
- 2020
- Total Funding
- 388,000,000
- Website
- caresyntax.com
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
FDA-validated CDaaS methodology via CQI (Clinical Quality Improvement); ethics board reviewed; 2024: 10 society presentations, 2 published manuscripts, 1 FDA indication expansion
MedStartr Index Score
?What do you think of CareSyntax?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.